The University of Kent has pledged not to conduct any sepsis experiments on animals after hearing from PETA, and now, others ...
ImmunoBrain, a clinical-stage biopharmaceutical company developing novel immunotherapies for neurodegenerative diseases, today announced the appointment of Francis S. Collins, MD, PhD, to its board of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback